Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. - Wikidata - awgldk - TriplyDB

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

http://www.wikidata.org/entity/Q36791229

about

Third-generation beta-adrenoceptor antagonists in the treatment of hypertension and heart failure Beta blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis G protein-coupled receptors in cardiac biology: old and new receptors It is time to ask what adenosine can do for cardioprotection.Is there a role for carvedilol in the management of pediatric heart failure? A meta analysis and e-mail survey of expert opinion.The rational use of beta-adrenoceptor blockers in the treatment of heart failure. The changing face of an old therapy Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.Advances in the treatment of congestive heart failure: new approaches for an old disease.Dyspnoea of cardiac origin in 67 year old men: (2). Relation to diastolic left ventricular function and mass. The study of men born in 1913.Importance of neuroendocrine activation in chronic heart failure. Impact on treatment strategies.beta-blockers in heart failure: recently completed and ongoing clinical trials.Heart Failure: Treatment strategies for heart failure: beta blockers andantiarrhythmics Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure.Mortality in heart failure: clinical variables of prognostic value beta-Blockers in congestive heart failure.New advances in the pharmacological management of chronic heart failure.Beta blockers for CHF. Adrenergic blockade dramatically reduces morbidity and mortality.Carvedilol in the treatment of chronic heart failure.Metoprolol CR/XL in the treatment of chronic heart failure.Beta-blocker treatment in heart failure.Treatment of chronic heart failure: a review of recent drug trials Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan.Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.Can intellectualism stifle scientific discovery?CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973].Extended-release metoprolol succinate in chronic heart failure.Beta blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol.Prediction of the effectiveness of long-term beta blocker treatment for dilated cardiomyopathy by signal averaged electrocardiography.The power of Pasteur's quadrant: cardiovascular disease at the turn of the century.Outpatient management of congestive heart failure The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure.A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling.The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study Beta-blocker therapy in unstable severe heart failure, evidence or experience?Bisoprolol in the treatment of chronic heart failure.Treatment of congestive cardiomyopathy.Cardiomyopathies in South Africa--a brief survey of the problem and current therapeutic approaches Beta-blocker therapy of heart failure: an update.Cardiac work and myocardial substrate extraction in congestive cardiomyopathy.

P2860

Q26822825-048AF535-F9AB-4D97-A81F-B7D92E28440A Q28379279-A35B0379-50D9-4353-B8B4-22102F15D16B Q28573405-CBA9DC82-40C9-49F9-9063-F09DE92C2649 Q33639685-9B3792C6-40C4-4798-8009-AAFFFDD76CD8 Q33731467-A63E5AEF-B0F1-4606-803B-2873D52FB5F0 Q33735757-78508B55-3D52-48AD-94CD-CA393B87D4DE Q33801164-17355AA3-C881-4A41-B42B-AF9945403D66 Q33838831-C578B1E3-F0C1-4642-88CC-388FC80DA546 Q33977639-602853EF-C737-47F0-9C59-2B3A1F87BFC8 Q33999427-8165D37E-6B54-4160-A936-28B3729F531A Q33999920-091DD18C-F95B-4039-9154-467ACBC59A4F Q34074729-C84D84F0-98FD-4112-A18A-DC4E940C6EB1 Q34105704-C02FD9A2-1627-4BC1-A6BA-CF72CC563836 Q34118183-2ED54705-CB4F-4A5C-A813-78D58B513F16 Q34118615-A785218F-5C15-4483-B25A-76AC38777AD5 Q34119535-6600D8C0-D49A-4D73-820D-55473F4B8DE7 Q34182249-CD4FD279-BB21-44DD-B882-E77679CB13AD Q34193584-56EC97AA-E990-4FFD-8C65-7578BEE0CB67 Q34241046-69D73F9B-5EF5-46CB-8357-46E979E08C75 Q34249410-214EBD83-DBD4-40E1-B8DB-9E1B86528AF3 Q34316468-486A3785-345E-4029-9499-B4771C2E434B Q34487586-FE91CC3D-B0E4-42FB-83BA-49529AEF357F Q34609451-2196F1D9-E374-4AD6-BDF8-C81BD733DFE8 Q34837191-C5F37FE0-AFFD-4D7C-BAD5-CEFE10A3A9BD Q34932240-28FB015D-1650-4E19-8997-EDB689505735 Q34973539-E60374B6-EBEF-4993-BE46-9FC25D80705C Q35112394-35C88C59-20B2-4219-BDEF-C894BFEED8A9 Q35366259-696FDBF8-2B71-404F-B2CB-F56A5348715A Q35366950-9587E6B8-C415-4C04-815D-6BB3C06A8F15 Q35559072-5EC85B1F-3B62-459B-9D04-B8B47E9F099A Q35665407-FEE63CEE-0822-4100-B5A3-EF765C957214 Q36013015-1C525683-C062-472F-8343-BC87287A330F Q36082162-39E36E9A-A59D-4177-91C7-CCB2FE38A520 Q36477727-8F0D238B-09FD-4995-89EE-5D5E80604682 Q36484589-170ED953-8695-4C85-B830-A5B2AF8FDBE8 Q36536259-4800963A-EB2D-4B6E-9E85-5A4DFAFCE8F8 Q36714860-2BA63914-D638-44C2-858D-C6286EBD1145 Q36714865-9CA02402-2685-452D-B87B-7AC83F4159A1 Q36723828-1470A3BE-F65E-4818-948F-3460A2287E2E Q36737831-733C9C02-F143-4ED4-90AE-743AD5A53D9C

P2860

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

http://www.wikidata.org/entity/Q36791229

description

1975 nî lūn-bûn

@nan

1975年の論文

@ja

1975年論文

@yue

1975年論文

@zh-hant

1975年論文

@zh-hk

1975年論文

@zh-mo

1975年論文

@zh-tw

1975年论文

@wuu

1975年论文

@zh

1975年论文

@zh-cn

name

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

@ast

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

@en

type

label

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

@ast

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

@en

prefLabel

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

@ast

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

@en

P1433

Q36791229-EF061570-B395-42D1-BB79-1F0DB9DF5A03

P1476

Q36791229-C1AD0CDD-1328-481A-B6AF-AF64B9812798

P2093

Q36791229-141F190A-CFF1-41F6-9EA2-B25D83E93C5F

Q36791229-30F0F72D-A35C-42AE-9E82-D1B8F78B8617

Q36791229-320E3C9A-7FA6-4E0B-B0FE-C362330E76EE

Q36791229-7EB56B84-30E9-4012-A6E9-F4BCCD23D8F2

P2860

Q36791229-0AF024CB-7DCE-4B33-963E-264E2FB42756

Q36791229-2BAF0414-06AF-4459-A8FD-6535B40B2B94

Q36791229-2D9FFAA7-3C7A-46E1-81F1-EF703E9040D8

Q36791229-3276B2E7-5FDD-4BF5-82FB-EB7C36727C85

Q36791229-3A7B97FE-E360-412B-8C16-C453E5E3E1DF

Q36791229-40061CFC-0FCD-4CD7-90BC-1EA629C8AC38

Q36791229-B6842393-C9FE-492B-B550-9E3040B2F0D2

Q36791229-D31F5ED8-18C9-4B82-B382-D21FECC18ECE

P304

Q36791229-378D9344-FE6F-4E0A-AE88-B56975970D84

P31

Q36791229-3A5E9F84-D72F-472A-89E0-E0A65EFF9781

P356

Q36791229-42288545-41D0-4357-A846-0A849175A279

P433

Q36791229-6D772A6B-D6D8-484C-A1BD-5AF22C78DDFA

P478

Q36791229-4DAF0489-35C6-43D4-9192-27389E9C5CC9

P577

Q36791229-3EACBB02-B465-4E8D-A18A-654C0F3885C0

P5875

Q36791229-8D25B8CD-FBE8-4CD7-8E19-D4999C90E399

P698

Q36791229-94DE849B-46C0-4E89-AE25-5503276A881D

P932

Q36791229-BE2995DB-196B-4311-AA2E-B126ABF13A3E

P356

P1433

British heart journal

P1476

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

@en

P2093

Hjalmarson A

http://www.w3.org/2001/XMLSchema#string

Varnauskas E

http://www.w3.org/2001/XMLSchema#string

Waagstein F

http://www.w3.org/2001/XMLSchema#string

Wallentin I

http://www.w3.org/2001/XMLSchema#string

P2860

The cardiomyopathies.

Apex cardiogram and systolic time intervals in acute myocardial infarction and effects of practolol.

Duration of phases of left ventricular systole using indirect methods. II. Acute myocardial infarction.

The 'A' wave of the apex cardiogram in aortic valve disease and cardiomyopathy.

Prospects and predictions for the cardiomyopathies.

Control of myocardial oxygen consumption: physiologic and clinical considerations.

Spontaneous, herditary myocardial degeneration and congestive heart failure in a strain of Syrian hamsters.

Estimation of left atrial size using ultrasound.

P304

1022-1036

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HRT.37.10.1022

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

1975-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21965070

http://www.w3.org/2001/XMLSchema#string

P698

1191416

http://www.w3.org/2001/XMLSchema#string

P932

482914

http://www.w3.org/2001/XMLSchema#string